We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.8M
AUM Growth
-$80M
(-55%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-199.18%
Top 10 Holdings %
Top 10 Hldgs %
49.58%
Holding
538
New
154
Increased
37
Reduced
174
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$7.91M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$888K |
| 3 |
Morgan Stanley
MS
|
+$644K |
| 4 |
Eli Lilly
LLY
|
+$522K |
| 5 |
Franklin Resources
BEN
|
+$368K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIMT
Aimmune Therapeutics
AIMT
|
+$18.5M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$8.78M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.64M |
| 4 |
Merck
MRK
|
+$637K |
| 5 |
CNX Resources
CNX
|
+$517K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.05% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 5.98% |
| 4 | Real Estate | 5.72% |
| 5 | Consumer Discretionary | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Medtronic
MDT
$105B
| $117K | 0.18% |
1,368
+1,032
| +307% | +$86.2K |
|
77
Johnson & Johnson
JNJ
$622B
| $116K | 0.18% |
953
-2,403
| -72% | -$300K |
|
|
EV
78
DELISTED
Eaton Vance Corp.
EV
| $109K | 0.17% |
2,079
-1,574
| -43% | -$86.7K |
|
79
APA Corp
APA
$13B
| $107K | 0.16% |
2,299
-954
| -29% | -$39.6K |
|
80
Donaldson
DCI
$10.6B
| $106K | 0.16% |
2,339
-2,227
| -49% | -$103K |
|
81
RingCentral
RNG
$3.23B
| $105K | 0.16% |
+1,497
| New | +$107K |
|
82
Tyler Technologies
TYL
$11.9B
| $105K | 0.16% |
472
-497
| -51% | -$112K |
|
83
Lincoln National
LNC
$7.85B
| $104K | 0.16% |
1,667
| – | – |
|
84
News Corp Class A
NWSA
$14.4B
| $102K | 0.15% |
6,569
-6,675
| -50% | -$105K |
|
|
HPP
85
Hudson Pacific Properties
HPP
$804M
| $101K | 0.15% |
406
-1,610
| -80% | -$380K |
|
86
Keurig Dr Pepper
KDP
$40.4B
| $100K | 0.15% |
+820
| New | +$98.5K |
|
87
Berkshire Hathaway Class B
BRK.B
$1.05T
| $99K | 0.15% |
531
-544
| -51% | -$106K |
|
88
SLB Ltd
SLB
$71B
| $99K | 0.15% |
+1,482
| New | +$102K |
|
89
AvalonBay Communities
AVB
$27.1B
| $98K | 0.15% |
568
-456
| -45% | -$75.4K |
|
90
Honeywell
HON
$77.3B
| $98K | 0.15% |
751
-2,518
| -77% | -$335K |
|
91
Kimco Realty
KIM
$17.4B
| $98K | 0.15% |
5,790
-10,565
| -65% | -$160K |
|
92
Synopsys
SNPS
$71.5B
| $98K | 0.15% |
1,151
-4,290
| -79% | -$374K |
|
93
Amphenol
APH
$193B
| $97K | 0.15% |
4,464
-18,648
| -81% | -$406K |
|
94
Amdocs
DOX
$5.42B
| $97K | 0.15% |
1,472
-5,336
| -78% | -$359K |
|
95
Genpact
G
$5.09B
| $97K | 0.15% |
3,339
-2,700
| -45% | -$83.5K |
|
|
CHK
96
DELISTED
Chesapeake Energy Corporation
CHK
| $97K | 0.15% |
93
-648
| -87% | -$502K |
|
|
MRSH
97
Marsh
MRSH
$83.6B
| $91K | 0.14% |
1,109
-6,034
| -84% | -$493K |
|
|
GRMN
98
Garmin
GRMN
$46.5B
| $90K | 0.14% |
1,474
-1,989
| -57% | -$119K |
|
99
UDR
UDR
$12.8B
| $89K | 0.14% |
+2,372
| New | +$85.8K |
|
100
Chevron
CVX
$390B
| $88K | 0.13% |
699
-1,080
| -61% | -$134K |
|
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q2 2018 Portfolio in Review
As of Q2 2018, TLP Group held 538 positions worth $65.8M, down 55% from $146M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
TLP Group withdrew a net $131M in Q2 2018, closing 157 positions and reducing 174 holdings. Its most notable exit was Aimmune Therapeutics, an estimated $18.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
Against the trend, TLP Group opened a new position in Franklin Resources worth $352K.
- TLP Group's largest Q2 2018 buy was Franklin Resources: 10,992 shares worth $352K.
- TLP Group added most to iShares Russell 2000 ETF in Q2 2018, an estimated $7.91M increase.
- TLP Group's biggest Q2 2018 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $8.78M.
- TLP Group fully exited Aimmune Therapeutics in Q2 2018, selling an estimated $18.5M.
- TLP Group's ten largest holdings make up 50% of its $65.8M portfolio in Q2 2018.
- TLP Group opened 154 new positions and closed 157 in Q2 2018.
- TLP Group's portfolio value fell 55% quarter-over-quarter to $65.8M.
Based on TLP Group's 13F filing for Q2 2018, filed 14 Aug 2018.